PAVmed (PAVM) Cash from Operations (2015 - 2025)

PAVmed has reported Cash from Operations for 11 years, with the latest figure at -$1.5 million in Q4 2025.

• On a quarterly basis, Cash from Operations fell 1702.13% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was -$5.2 million, a 85.75% increase from a year earlier, with the FY2025 full-year figure at -$5.2 million, up 84.48% from the prior year.
• Cash from Operations was -$1.5 million for Q4 2025 at PAVmed, down from -$941000.0 in the prior quarter.
• The five-year high for Cash from Operations was $94000.0 in Q4 2024, with the low at -$22.6 million in Q2 2022.
• Average Cash from Operations over 5 years is -$10.2 million, with a median of -$11.7 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 100.79% in 2024, then sank 1702.13% in 2025.
• Over 5 years, Cash from Operations stood at -$16.8 million in 2021, then decreased by 0.27% to -$16.8 million in 2022, then advanced by 29.42% to -$11.9 million in 2023, then jumped by 100.79% to $94000.0 in 2024, then tumbled by 1702.13% to -$1.5 million in 2025.
• The last three Cash from Operations figures came in at -$1.5 million (Q4 2025), -$941000.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.